Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. - Wikidata - wikimedia - TriplyDB

Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer.

Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer.

http://www.wikidata.org/entity/Q39635993

about

Cell-free DNA as a diagnostic marker for cancer: current insights Detection of circulating tumor DNA in early- and late-stage human malignancies Getting more from digital SNP data.DNA degradation test predicts success in whole-genome amplification from diverse clinical samples.Plasma circulating nucleic acids levels increase according to the morbidity of Plasmodium vivax malaria.Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy Circulating tumour markers can define patients with normal colons, benign polyps, and cancers.DNA methylation changes in prostate cancer: current developments and future clinical implementation.Promising directions for the diagnosis and management of gynecological cancers.Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma.Circulating nucleic acids and proteomics of plasma/serum: clinical utility.Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.Digital PCR for the molecular detection of fetal chromosomal aneuploidy Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients.The mitogen-activated protein kinase phosphatase-1 (MKP-1) gene is a potential methylation biomarker for malignancy of breast cancer.Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis.Cell-Free DNA Provides a Good Representation of the Tumor Genome Despite Its Biased Fragmentation Patterns.Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats.Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.Serum efficacy biomarkers for oncology.Generation, function, and prognostic utility of somatic mitochondrial DNA mutations in cancer.Restoring TRAIL mediated signaling in ovarian cancer cells.Strategies for validation and testing of DNA methylation biomarkers.Methylated tumor-specific DNA as a plasma biomarker in patients with glioma.Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.Diagnostic and prognostic value of plasma and tissue ubiquitin-like, containing PHD and RING finger domains 1 in breast cancer patients.Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA.Alu-based cell-free DNA: a novel biomarker for screening of gastric cancer.Diagnostic relevance of plasma DNA and DNA integrity for breast cancer.Detecting lung cancer in plasma with the use of multiple genetic markers.Cell-free plasma DNA as biochemical biomarker for the diagnosis and follow-up of prostate cancer patients.Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer.Circulating free DNA in plasma or serum as biomarkers of carcinogenesis in colon cancer.Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer.Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value.dPCR: A Technology Review.Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy.

P2860

Q28074556-8D5DFF0A-1850-4D29-A235-B58114D2920C Q29615778-29834852-CD44-4494-9C69-4DDBD68F8DF3 Q31028867-F44C1FB2-C0B7-4F56-B66D-9E129DC6550D Q33293788-37CB027D-F323-4952-99D8-18C68BB2F611 Q33395491-439416D5-81DF-4A37-AB75-24BA0691D36D Q33790229-23D3AD14-3E3B-4FA2-BA4F-D1E03B63B3FD Q33980278-F883005A-9422-4E67-B146-A61955BF254B Q35125657-924F5121-0E22-48D8-A3D2-818734544B7B Q35636543-1A0E3B71-3DDE-47FD-BCF8-D870A5771085 Q35648859-1DC19E41-D371-43D1-BE6F-508B5E4C4E6E Q35790070-13EA7232-AC3F-45C8-8F27-D513873196D2 Q35835700-9E5B0665-6234-4AE4-9C9B-3DE55F5DA91A Q35881722-5912CA07-9257-4CF9-9FA3-06D4718A2052 Q35916813-88CF3035-CA00-4971-8EBF-257AF3A7A6DA Q35995428-1BCAE96E-DCD2-4195-99CF-52B7D21971A8 Q36005081-3DA2507D-2B4D-4D7D-9700-24A2E83F43BD Q36037774-25F4B1A9-F788-4D18-9ECC-48A791EBCDEB Q36238197-DA127C65-E81C-48E1-9562-40C435C06C4A Q36597182-CABC7D83-5617-4AB2-A144-EDD51DBA2765 Q37014663-3421FA0B-273D-48A6-914B-54655C1D7F8B Q37728847-858B56BA-7AFF-445F-A05C-B21425A23B59 Q37755150-5EC25272-8B59-4AD5-B77E-5255316E7B95 Q37764795-731095DC-39BD-49B5-AB4C-5E0334540F75 Q38230205-73178E89-DD4A-4DD1-BD9D-2591F9329244 Q38296746-2F6E2351-76E1-4EFF-BF77-3BFC1CD5DDE7 Q38316068-4C01B0A2-B2D7-4722-B8EF-6A5381ABBBC7 Q38435223-B06C1132-94A0-476E-90A4-E6CF5F1DE575 Q39252224-167EB1CC-9324-48F3-89CD-2CB959F88C03 Q39344296-7BFE8E46-06CC-49CA-8168-3A336C7FB1C1 Q41553436-81D89D0E-FA53-4673-86A2-58BE65935AF2 Q44158160-079892EF-7B0C-48D0-8691-10AA21332C19 Q44656374-CA8FF15B-2B45-4888-ACDB-54983DDCCD38 Q45323416-BE76020F-A2D1-4AA7-8BC8-A8A59D5DF88B Q46156629-01A6644B-642A-460C-9254-5C1716E98B80 Q46790693-DFAEDEB1-8BA7-4CBF-BA55-674486B8C05C Q48486711-39DFCA99-AB93-4D92-B34E-B01E59322883 Q50155659-F86B5221-4F08-4881-93D5-4F64A3497F35 Q51914571-724A25B3-9CF8-4039-ADA2-E1BEF61FEA70 Q52574457-35A1E1DB-EB12-4BA2-9700-4E9692D14ABD Q54537328-B9977D20-79F4-492C-9135-90A9477EA691

P2860

Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer.

http://www.wikidata.org/entity/Q39635993

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Assessment of plasma DNA level ...... s diagnostic tests for cancer.

@en

Assessment of plasma DNA level ...... s diagnostic tests for cancer.

@nl

type

label

Assessment of plasma DNA level ...... s diagnostic tests for cancer.

@en

Assessment of plasma DNA level ...... s diagnostic tests for cancer.

@nl

prefLabel

Assessment of plasma DNA level ...... s diagnostic tests for cancer.

@en

Assessment of plasma DNA level ...... s diagnostic tests for cancer.

@nl

P1433

Q39635993-A47AD904-1DC8-45E2-B8AA-36E339609575

P1476

Q39635993-185C8636-E24A-45E8-AC6A-0D17924629F9

P2093

Q39635993-0256525F-869D-4F0C-B0AE-92B793593AB2

Q39635993-1F0ECB83-AD1A-4408-B724-7E04F5788038

Q39635993-219425D4-79AC-428A-AC86-BB84F3183EAF

Q39635993-5E0017B5-CB15-4E50-901F-19A9533DD838

Q39635993-7CADBD95-1ECA-41CF-BC26-161DB30BEB6C

Q39635993-9E0C1482-74DA-4D81-8B42-E94CD86E0616

Q39635993-AE6F39C2-554F-4345-8109-D3440F1AB0B2

Q39635993-CDD708A3-6571-44DC-B2ED-0A1D8BA9DFB9

Q39635993-CEE17B58-80F4-4374-8437-5E79E0A06EC8

Q39635993-DD9330E2-B035-4424-80A3-9ACC52EEFC40

P304

Q39635993-E93AF2C7-5112-4A3A-AE46-47FBA1181C4E

P31

Q39635993-DFF10765-2306-49F6-9636-B549ACCABB2F

P356

Q39635993-E50293ED-A557-42CD-83BF-B01EF46ECC60

P407

Q39635993-EAF91BC2-1C8C-4C3B-B3B7-17765DF8A421

P433

Q39635993-D4EC9626-2D41-42C5-BECE-34EE47C8962C

P478

Q39635993-5BAD68DA-DB61-44DF-9DE9-8DAC57961972

P577

Q39635993-371399D5-C49F-4102-BD28-0F63766B4BBC

P5875

Q39635993-D7E09901-27FA-48A4-AE65-7A5D557A0FA0

P698

Q39635993-2867202C-3911-4FCE-957F-5FC440B2FEF1

P356

P1433

Journal of the National Cancer Institute

P1476

Assessment of plasma DNA level ...... s diagnostic tests for cancer.

@en

P2093

Daniel W Chan

http://www.w3.org/2001/XMLSchema#string

Fredrick J Montz

http://www.w3.org/2001/XMLSchema#string

Gad Singer

http://www.w3.org/2001/XMLSchema#string

Hsueh-Wei Chang

http://www.w3.org/2001/XMLSchema#string

Ie-Ming Shih

http://www.w3.org/2001/XMLSchema#string

Lori J Sokoll

http://www.w3.org/2001/XMLSchema#string

Richard Roden

http://www.w3.org/2001/XMLSchema#string

Robert J Kurman

http://www.w3.org/2001/XMLSchema#string

Sarah K R Cho

http://www.w3.org/2001/XMLSchema#string

Shing M Lee

http://www.w3.org/2001/XMLSchema#string

P304

1697-1703

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/94.22.1697

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275298900

http://www.w3.org/2001/XMLSchema#string

P698

12441325

http://www.w3.org/2001/XMLSchema#string